Concepedia

Nicola Broadbent

NB

Statistics

Publications

3

Citations

217

H-Index

3

Active since

2011

Affiliations

AstraZeneca (United Kingdom)(Current)

Nicola Broadbent is an author at AstraZeneca (United Kingdom) specializing in medicine, oncology, and hormonal cancer therapy.

Publications per year

2011–2013

3

Publications

3

Assessing the Activity of Cediranib, a VEGFR-2/3 Tyrosine Kinase Inhibitor, against VEGFR-1 and Members of the Structurally Related PDGFR Family

Sandra R. Brave, Kirsty Ratcliffe, Zena Wilson et al. · Molecular Cancer Therapeutics · 2011 · 88 citations · Full text

, , +15

AZD3514: A Small Molecule That Modulates Androgen Receptor Signaling and Function <i>In Vitro</i> and <i>In Vivo</i>

Sarah A. Loddick, Sarah J. Ross, Andrew Thomason et al. · Molecular Cancer Therapeutics · 2013 · 77 citations · Full text

, , +17

Discovery of AZD3514, a small-molecule androgen receptor downregulator for treatment of advanced prostate cancer

Robert H. Bradbury, David Acton, Nicola Broadbent et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 52 citations · Full text

, , +14

1–3 of 3